How can we improve antidepressant adherence in the management of depression? A targeted review and 10 clinical recommendations
Braz. J. Psychiatry (São Paulo, 1999, Impr.)
;
43(2): 189-202, Mar.-Apr. 2021. tab, graf
Artículo
en Inglés
| LILACS
| ID: biblio-1285525
ABSTRACT
Adherence to antidepressants is crucial for optimal treatment outcomes when treating depressive disorders. However, poor adherence is common among patients prescribed antidepressants. This targeted review summarizes the main factors associated with poor adherence, interventions that promote antidepressant adherence, pharmacological aspects related to antidepressant adherence, and formulates 10 clinical recommendations to optimize antidepressant adherence. Patient-related factors associated with antidepressant non-adherence include younger age, psychiatric and medical comorbidities, cognitive impairment, and substance use disorders. Prescriber behavior-related factors include neglecting medical and family histories, selecting poorly tolerated antidepressants, or complex antidepressant regimens. Multi-disciplinary interventions targeting both patient and prescriber, aimed at improving antidepressant adherence, include psychoeducation and providing the patient with clear behavioral interventions to prevent/minimize poor adherence. Regarding antidepressant choice, agents with individually tailored tolerability profile should be chosen. Ten clinical recommendations include four points focusing on the patient (therapeutic alliance, adequate history taking, measurement of depressive symptoms, and adverse effects improved access to clinical care), three focusing on prescribing practice (psychoeducation, individually tailored antidepressant choice, simplified regimen), two focusing on mental health services (improved access to mental health care, incentivized adherence promotion and monitoring), and one relating to adherence measurement (adherence measurement with scales and/or therapeutic drug monitoring).
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Depresión
/
Antidepresivos
Tipo de estudio:
Guía de Práctica Clínica
Límite:
Humanos
Idioma:
Inglés
Revista:
Braz. J. Psychiatry (São Paulo, 1999, Impr.)
Asunto de la revista:
Psiquiatria
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
Australia
/
Brasil
/
Italia
/
Estados Unidos
/
Reino Unido
Institución/País de afiliación:
Anglia Ruskin University/GB
/
Azienda Ospedale Università di Padova/IT
/
Northwell+US
/
Institute for Mental and Physical Health and Clinical Translation (IMPACT Strategic Research Centre), School of Medicine, Barwon Health, Deakin University/AU
/
Programa de Pós-Graduação em Ciências da Saúde, Laboratório de Neurociências, Unidade de Ciências da Saúde, Universidade do Extremo Sul Catarinense (UNESC)/BR
/
Università Federico II/IT
/
Università di Padova/IT
Similares
MEDLINE
...
LILACS
LIS